Dominic Wall

Dominic Wall is the Executive Director of Business Ventures at Peter MacCallum Cancer Centre, a prominent cancer research and treatment institution in Australia.1 Here's an overview of his background and responsibilities:

Professional Role

Dominic Wall leads Peter Mac's existing and emerging business ventures programs.1 His key responsibilities include:

• Overseeing the national Centre of Excellence in Cellular Immunotherapy at Peter Mac
• Leading Peter Mac's Pathology services
• Managing Nexomics, a business unit providing specialized accredited medical oncology testing for clinical research

Additionally, he serves as the Chief Scientific Officer of Cell Therapies Pty Ltd, a majority-owned independent commercial business of Peter Mac.1

Expertise and Experience

Cell Therapy and Immunotherapy: Dominic has been directly involved in cell therapy manufacturing since the 1990s and was responsible for manufacturing Australia's first CAR-T products in 2008.1 He is an expert in CAR-T cell process development and analytics.3

Pathology and Laboratory Services: As the responsible person for Pathology Operations at Peter Mac, Dominic oversees a comprehensive range of pathology services, including haematology, flow cytometry, anatomical pathology, and molecular pathology.2

Regulatory Expertise: Dominic is recognized as a regulatory expert in the field of cell therapy. He chairs the Legal & Regulatory Subcommittee of the International Society for Cell Therapy (ANZ) and has served as a regional vice-president for three terms.2

Education and Qualifications

• PhD from the University of Melbourne
• BSc (Hons) from the University of London School of Pathology
• Fellow of the Faculty of Science (FFSc) from the Royal College of Pathologists of Australasia12

Research and Publications

Dominic has published over 130 papers and abstracts in his field and is cited by 1333 publications according to his ResearchGate profile.4

Dominic Wall's extensive experience in cell therapy, pathology, and business ventures makes him a key figure in advancing cancer research and treatment at Peter MacCallum Cancer Centre.